These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29157550)

  • 21. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw.
    Goodday RH
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):527-36. PubMed ID: 26293331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mixed radiopaque and radiolucent jaw lesions].
    Milicevic M
    Rev Med Liege; 2017 Mar; 72(3):151-155. PubMed ID: 28387493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.
    Kagami H; Inoue M; Kobayashi A; Taguchi A; Li X; Yoshizawa M
    Oral Dis; 2018 Mar; 24(1-2):52-56. PubMed ID: 29480637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic imaging of drug-induced osteonecrosis of the jaw].
    Hingst V; Weber MA
    Radiologe; 2018 Oct; 58(10):935-948. PubMed ID: 30187078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteonecrosis of the jaws: what the physician needs to know: practical considerations.
    Abughazaleh K; Kawar N
    Dis Mon; 2011 Apr; 57(4):231-41. PubMed ID: 21569888
    [No Abstract]   [Full Text] [Related]  

  • 27. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
    Fleisher KE; Glickman RS
    J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
    [No Abstract]   [Full Text] [Related]  

  • 29. Biophosphonate-related osteonecrosis of the jaws.
    Ruggiero SL; Woo SB
    Dent Clin North Am; 2008 Jan; 52(1):111-28, ix. PubMed ID: 18154867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetracycline bone fluorescence: a valuable marker for osteonecrosis characterization and therapy.
    Pautke C; Bauer F; Bissinger O; Tischer T; Kreutzer K; Steiner T; Weitz J; Otto S; Wolff KD; Stürzenbaum SR; Kolk A
    J Oral Maxillofac Surg; 2010 Jan; 68(1):125-9. PubMed ID: 20006166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate-related osteonecrosis of the jaws.
    Kushner GM; Alpert B
    Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
    Tabari E; Sikavi C
    Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
    Schmitt CM; Buchbender M; Lutz R; Neukam FW
    Eur J Oral Implantol; 2018; 11 Suppl 1():S93-S111. PubMed ID: 30109302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication-Related Osteonecrosis of the Jaw.
    Chen YF; Chang HP
    N Engl J Med; 2023 May; 388(21):e69. PubMed ID: 37212416
    [No Abstract]   [Full Text] [Related]  

  • 37. Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis.
    Obinata K; Shirai S; Ito H; Nakamura M; Carrozzo M; Macleod I; Carr A; Yamazaki Y; Tei K
    Dentomaxillofac Radiol; 2017 Jul; 46(5):20160281. PubMed ID: 28186845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
    McGowan K; Ivanovski S; Acton C
    Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
    Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.